Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Takeda Pharmaceutical Co. Ltd ADR (TAK)

Takeda Pharmaceutical Co. Ltd ADR (TAK)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 44,619,520
  • Shares Outstanding, K 3,164,505
  • Annual Sales, $ 30,059 M
  • Annual Income, $ 3,534 M
  • 60-Month Beta 1.03
  • Price/Sales 1.46
  • Price/Cash Flow 3.85
  • Price/Book 0.92
Trade TAK with:

Options Overview Details

View History
  • Implied Volatility 24.63%
  • Historical Volatility 41.61%
  • IV Percentile 35%
  • IV Rank 10.19%
  • IV High 74.63% on 10/30/20
  • IV Low 18.96% on 05/26/21
  • Put/Call Vol Ratio 0.07
  • Today's Volume 1,348
  • Volume Avg (30-Day) 1,620
  • Put/Call OI Ratio 0.33
  • Today's Open Interest 54,780
  • Open Int (30-Day) 47,745

Analyst Rating / Earnings Estimates

Current Rating
See More
Hold
Based on 3 analysts offering recommendations.
Earnings Estimates - Current Qtr 09/30/21
See More
  • Average Estimate N/A
  • Number of Estimates 0
  • High Estimate N/A
  • Low Estimate N/A
  • Prior Year 0.47
  • Growth Rate Est. (year over year) +212,453.19%

Price Performance

See More
Period Period Low Period High Performance
1-Month
13.91 +1.65%
on 10/18/21
17.31 -18.31%
on 09/21/21
-2.92 (-17.12%)
since 09/20/21
3-Month
13.91 +1.65%
on 10/18/21
17.31 -18.31%
on 09/21/21
-2.87 (-16.87%)
since 07/20/21
52-Week
13.91 +1.65%
on 10/18/21
19.97 -29.18%
on 03/22/21
-2.53 (-15.18%)
since 10/20/20

Most Recent Stories

More News
Seagen's (SGEN) Cancer Portfolio Strong, Stiff Rivalry a Worry

Seagen (SGEN) focuses on improving sales of its marketed drugs that are approved for different types of cancer indications. Stiff competition in the target market remains a woe.

RHHBY : 47.7600 (-1.63%)
SGEN : 174.85 (+0.38%)
TAK : 14.14 (+0.28%)
GMAB : 45.84 (+1.19%)
BioLife Plasma Services Announces Expansion of Plasma Donation Centers into Massachusetts

BioLife Plasma Services, part of the global biopharmaceutical company Takeda, today announced the opening of a new plasma center in Worcester, MA, to help meet the urgent and growing demand for therapies...

TAK : 14.14 (+0.28%)
FDA Advisory Committee Recommends Use of Investigational Drug Maribavir (TAK-620) to Treat Post-Transplant Recipients with Cytomegalovirus (CMV) Infection and Disease Refractory to Treatment With or Without Resistance

Takeda Pharmaceutical Company Limited ( TSE:4502/NYSE:TAK ) (“Takeda”) today announced the U.S. Food and Drug Administration (FDA) Antimicrobial Drugs Advisory Committee (AMDAC) voted unanimously to...

TAK : 14.14 (+0.28%)
Takeda Provides Update on TAK-994 Clinical Program

Takeda Pharmaceutical Company Limited ( TSE:4502/NYSE:TAK ) (“Takeda”) today announced that a safety signal has emerged in Phase 2 studies of TAK-994, an investigational oral orexin agonist. As an...

TAK : 14.14 (+0.28%)
The Latest: Philippines imposes airport entry restrictions

MANILA, Philippines — The Philippine government has decided to temporarily ban the entry of foreigners and limit the entry of returning Filipinos at Manila’s international airport to 1,500 daily as...

TAK : 14.14 (+0.28%)
JNJ : 163.78 (-0.05%)
The Latest: China donates vaccine doses to UN peacekeepers

UNITED NATIONS -- China’s U.N. ambassador says China is donating 300,000 doses of COVID-19 vaccines to U.N. peacekeepers, with priority given to those serving in Africa.

JNJ : 163.78 (-0.05%)
TAK : 14.14 (+0.28%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Sell with a Strengthening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

The market is in highly oversold territory. Beware of a trend reversal.

See More Share

Business Summary

Takeda Pharmaceutical Company Limited operates as a research-based pharmaceutical company, engaged in manufacturing, marketing, and importing/exporting pharmaceutical drugs. Takeda's core business comprise of ethical drugs and its portfolio includes lansoprazole for the treatment of peptic ulcers, leuprolide...

See More

Key Turning Points

3rd Resistance Point 14.27
2nd Resistance Point 14.24
1st Resistance Point 14.19
Last Price 14.14
1st Support Level 14.11
2nd Support Level 14.08
3rd Support Level 14.03

See More

52-Week High 19.97
Fibonacci 61.8% 17.65
Fibonacci 50% 16.94
Fibonacci 38.2% 16.22
Last Price 14.14
52-Week Low 13.91

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar